The Evolving Landscape of GLP-1 Therapy in US Pharmacies: A Comprehensive GuideThe landscape of metabolic health in the United States has undergone a seismic shift over the last couple of years. Central to this change is the rise of Glucagon-like Peptide-1 (GLP-1) receptor agonists. Originally developed to manage Type 2
